When was MedicSen founded?

MedicSen was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is MedicSen located?

MedicSen is headquartered in Madrid, Spain.

Who is the current CEO of MedicSen?

Eduardo W. Jorgensen de Vizcarrondo of MedicSen.

Is MedicSen a funded company?

MedicSen is a funded company, having raised an undisclosed amount across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 08, 2016.

When was the latest funding round of MedicSen?

MedicSen's latest funding was a $***** Grant (prize money) round on Apr 29, 2024, with participation from 3 investors.

Where does MedicSen rank among its competitors?

MedicSen ranks 47th amongst 294 active competitors, of which 36 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was CeQur, which secured $100M in Jun, 2026.

Who are the top competitors of MedicSen?

MedicSen's top competitors include BeatO, Glooko and CeQur. Among them, CeQur secured the most recent funding round in June, 2026.

MedicSen - 2026 Company Profile, Team, Funding & Competitors

Company Details

MedicSen offers a mobile application that can monitor and predict future glucose levels and recommends meals, insulin doses and exercise to manage diabetes. The application can also automatically collect data from connected glucometers. The company is also developing Smart-patch for the administration of insulin without needles, that will take information from the App to personalize the treatment automatically according to the needs of the patient.

Website: medicsen.com/en/
Social
Email ID: *****@medicsen.com
Phone Number: +34 **********

Key Metrics

Founded Year

2015

Location

Madrid, Spain

Stage

Seed

Latest Funding Round

Grant (prize money), Apr 29, 2024, $*****

Investors

TURN8 & 13 more

Ranked

47^th among 294 active competitors

Similar Companies

BeatO & 481 more

View MedicSen's full profile

MedicSen has raised funding over 8 rounds. Its first funding round was on Dec 08, 2016. Its latest funding round was a Grant (prize money) round on Apr 29, 2024 for $*****. 3 investors participated in its latest round. MedicSen has 14 institutional investors.

Here is the list of recent funding rounds of MedicSen:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 29, 2024	3923965	Grant (prize money)	8311833	9365545	9324201	9459587
2022	2906	Grant (prize money)	1306	1009	8050	EIC Fund
May 06, 2020	1756214	Grant (prize money)	9322256	3195645	1610848	SpinLab

Access funding benchmarks and valuations. Sign up today!

View details of MedicSen's funding rounds and investors

The founders of MedicSen are Eduardo W. Jorgensen de Vizcarrondo and Patricia Cremades Belmonte.

Here are the details of MedicSen's key team members:

Eduardo W. Jorgensen de Vizcarrondo: Co-Founder & CEO of MedicSen.
Patricia Cremades Belmonte: Founder & CSO of MedicSen.
Contact Info: 1 email address

View details of MedicSen's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MedicSen include BeatO, Glooko and CeQur. Here is the list of Top 10 competitors of MedicSen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BeatO 2015, Delhi (India), Series B	Provider of a smartphone-enabled glucometer and diabetes management app	$50.8M	Orios Venture Partners, W Health Ventures ... & 62 others	68/100
2nd	Glooko 2010, Palo Alto (United States), Series F	Glucose meter and mobile app for diabetes management	$201M	Social Capital, Georgian & 21 others	67/100
3rd	CeQur 2008, Horw (Switzerland), Series E	Developer of wearable insulin delivery patch	$492M	Endeavour Vision, Schroders & 7 others	59/100
4th	Health2Sync 2013, Taipei (Taiwan), Series C	Provider of an app for tracking blood glucose level	$30.5M	Taiwania Capital, Sompo Holdings & 12 others	56/100
5th	January 2017, San Francisco (United States), Series B	AI-powered precision health platform delivering personalized insights and recommendations	$28.3M	Hand Capital, AME Cloud Ventures & 8 others	54/100
6th	Tidepool 2012, San Francisco (United States), Seed	Diabetes data management platform empowering accessible, actionable, and meaningful insights	$1.5M	JDRF, Harrison Metal & 8 others	51/100
7th	Dr. Diary Co 2017, Seoul (South Korea), Series B	Provider of app for diabetes management	$12.2M	Shinhan Financial Group, Smile Gate Investment ... & 5 others	50/100
8th	EoFlow 2011, Seongnam-si (South Korea), Acquired	Developer of a wearable disposable insulin patch for diabetes patients	-	LB Investment, KIC Silicon Valley & 2 others	48/100
9th	Valeritas 2003, Bridgewater (United States), Acquired	Developer of wearable insulin patch pumps for insulin delivery through the skin	$231M	Welsh, Carson, Anderson & Stowe, Abingworth ... & 12 others	46/100
10th	LibreLinkUp 2016, Orlando (United States), Unfunded	Provider of diabetes management platform for patients	-	-	45/100
47th	MedicSen 2015, Madrid (Spain), Seed	Mobile app to manage diabetes	-	EIC Fund, Europa & 12 others	34/100